Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBAVIRIN Cause Systemic inflammatory response syndrome? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Systemic inflammatory response syndrome have been filed in association with RIBAVIRIN (Ribavirin). This represents 0.0% of all adverse event reports for RIBAVIRIN.

6
Reports of Systemic inflammatory response syndrome with RIBAVIRIN
0.0%
of all RIBAVIRIN reports
3
Deaths
6
Hospitalizations

How Dangerous Is Systemic inflammatory response syndrome From RIBAVIRIN?

Of the 6 reports, 3 (50.0%) resulted in death, 6 (100.0%) required hospitalization, and 4 (66.7%) were considered life-threatening.

Is Systemic inflammatory response syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBAVIRIN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does RIBAVIRIN Cause?

Fatigue (5,565) Anaemia (5,130) Nausea (4,434) Headache (3,497) Rash (2,686) Insomnia (2,653) Pruritus (2,490) Pyrexia (2,487) Drug ineffective (2,364) Vomiting (2,280)

What Other Drugs Cause Systemic inflammatory response syndrome?

DOXORUBICIN (161) METHOTREXATE (158) CYCLOPHOSPHAMIDE (153) CYTARABINE (153) METHYLPREDNISOLONE (117) ADALIMUMAB (107) RITUXIMAB (106) PREDNISOLONE (99) VINCRISTINE (97) MYCOPHENOLATE MOFETIL (95)

Which RIBAVIRIN Alternatives Have Lower Systemic inflammatory response syndrome Risk?

RIBAVIRIN vs RIBOCICLIB RIBAVIRIN vs RIBOFLAVIN RIBAVIRIN vs RIBOFLAVIN 5'-PHOSPHATE RIBAVIRIN vs RIBOFLAVIN 5^-PHOSPHATE RIBAVIRIN vs RIFABUTIN

Related Pages

RIBAVIRIN Full Profile All Systemic inflammatory response syndrome Reports All Drugs Causing Systemic inflammatory response syndrome RIBAVIRIN Demographics